Abstract
A study of 203 patients with chronic heart block treated with oral long-acting isoprenaline showed that 85 (42%) were maintained satisfactorily on the drug for a mean period of 18.2 months. The survival rates at one, two, and three years were 76%, 64%, and 57% respectively. In 115 patients treatment by pacing became necessary to control symptoms, and in these patients the survival rates at one, two and three years were 83%, 72%, and 60%.
The two most valuable guides to patients' response to oral isoprenaline are the response to a trial dose of intravenous isoprenaline and the type of dysrhythmia associated with their Adams-Stokes attacks. Patients with heart failure with slow ventricular rates and those with angina of effort do not respond to treatment with sympathomimetic drugs.
The majority of patients with chronic heart block are elderly, and in view of the complexity of pacing systems, and the need for skilled supervision of paced patients, oral long-acting isoprenaline remains of value in the longterm management of chronic heart block, provided patients are carefully selected for this form of therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aber C. P., Jones E. W. Corticotrophin and corticosteroids in the management of acute and chronic heart block. Br Heart J. 1965 Nov;27(6):916–925. doi: 10.1136/hrt.27.6.916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DACK S. MANAGEMENT OF THE STOKES-ADAMS SYNDROME. Am Heart J. 1963 Nov;66:579–583. doi: 10.1016/0002-8703(63)90312-0. [DOI] [PubMed] [Google Scholar]
- DACK S., ROBBIN S. R. Treatment of heart block and Adams-Stokes syndrome with sustained-action isoproterenol. JAMA. 1961 May 13;176:505–512. doi: 10.1001/jama.1961.03040190027008. [DOI] [PubMed] [Google Scholar]
- FLEMING H. A., MIRAMS J. A. A clinical trial of a sustained-action preparation of isoprenaline in the treatment of heartblock. Lancet. 1963 Aug 3;2(7301):214–217. doi: 10.1016/s0140-6736(63)90114-4. [DOI] [PubMed] [Google Scholar]
- FRIEDBERG C. K., KAHN M., SCHEUER J., BLEIFER S., DACK S. Adams-Stokes syndrome associated with chronic heart block. Treatment with corticosteroids. J Am Med Assoc. 1960 Mar 12;172:1146–1152. doi: 10.1001/jama.1960.03020110030008. [DOI] [PubMed] [Google Scholar]
- LEVINE S. A., MILLER H., PENTON G. B. Some clinical features of complete heart block. Circulation. 1956 Jun;13(6):801–824. doi: 10.1161/01.cir.13.6.801. [DOI] [PubMed] [Google Scholar]
- NATHANSON M. H., MILLER H. The action of norepinephrine, epinephrine and isopropyl norepinephrine on the rhythmic function of the heart. Circulation. 1952 Aug;6(2):238–244. doi: 10.1161/01.cir.6.2.238. [DOI] [PubMed] [Google Scholar]
- ROBBIN S. R., GOLDFEIN S., SCHWARTZ M. J., DACK S. Adams-Stokes syndrome; the treatment of ventricular asystole, ventricular tachycardia and ventricular fibrillation associated with complete heart block. Am J Med. 1955 Apr;18(4):577–590. doi: 10.1016/0002-9343(55)90458-7. [DOI] [PubMed] [Google Scholar]
- ROWE J. C., WHITE P. D. Complete heart block: a follow-up study. Ann Intern Med. 1958 Aug;49(2):260–270. doi: 10.7326/0003-4819-49-2-260. [DOI] [PubMed] [Google Scholar]
- Redwood D. Intravenous isoprenaline and orciprenaline as a guide to the drug treatment of Stokes-Adams attacks. Br Med J. 1968 Feb 17;1(5589):419–421. doi: 10.1136/bmj.1.5589.419. [DOI] [PMC free article] [PubMed] [Google Scholar]